Author

Parastoo Shahrouzi

Oslo University HospitalORCID 0000-0001-5797-1578Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1

Frequent Co-Authors

Vessela Nedelcheva KristenseniD· 2 shared Xavier TekpliiD· 2 shared Daniel OsorioiD· 1 shared David KunkeiD· 1 shared Derek J. RichardiD· 1 shared Marieke L. KuijjeriD· 1 shared Pascal H. G. DuijfiD· 1 shared Sugandha BhatiaiD· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Vessela Nedelcheva KristensenORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyBreast Cancer ResearchPeer-reviewedNov 27, 2024

Loss of chromosome cytoband 13q14.2 orchestrates breast cancer pathogenesis and drug response

Parastoo Shahrouzi, Youness Azimzade, Wioletta Brankiewicz…·Pascal H. G. Duijf

This study identifies the loss of chromosome 13q14.2 as a key driver of breast cancer pathogenesis and drug response, showing its impact on tumor survival, cell cycle, and treatment susceptibility.

5 citations

humanbulk RNA-seq

𝕏 PostBluesky

BioinformaticsbioRxivPreprintMar 31, 2022

Drug combination prediction for cancer treatment using disease-specific drug response profiles and single-cell transcriptional signatures

Daniel Osorio, Parastoo Shahrouzi, Xavier Tekpli…·Marieke L. Kuijjer

The paper develops a computational tool to predict drug combinations for TNBC by integrating transcriptional signatures with drug response data.

4 citations

humanscRNA-seq

𝕏 PostBluesky